Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation

被引:582
作者
Leng, RP
Lin, YP
Ma, WL
Wu, H
Lemmers, B
Chung, S
Parant, JM
Lozano, G
Hakem, R
Benchimol, S
机构
[1] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada
[3] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[4] Univ Hlth Network, Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada
[5] Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Houston, TX 77030 USA
基金
加拿大健康研究院;
关键词
D O I
10.1016/S0092-8674(03)00193-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 tumor suppressor exerts anti-proliferative effects in response to various types of stress including DNA damage and abnormal proliferative signals. Tight regulation of p53 is essential for maintaining normal cell growth and this occurs primarily through post-translational modifications of p53. Here, we describe Pirh2, a gene regulated by p53 that encodes a RING-H2 domain-containing protein with intrinsic ubiquitin-protein ligase activity. Pirh2 physically interacts with p53 and promotes ubiquitination of p53 independently of Mdm2. Expression of Pirh2 decreases the level of p53 protein and abrogation of endogenous Pirh2 expression increases the level of p53. Furthermore, Pirh2 represses p53 functions including p53-dependent transactivation and growth inhibition. We propose that Pirh2 is involved in the negative regulation of p53 function through physical interaction and ubiquitin-mediated proteolysis. Hence, Pirh2, like Mdm2, participates in an autoregulatory feedback loop that controls p53 function.
引用
收藏
页码:779 / 791
页数:13
相关论文
共 42 条
  • [1] Conformation-dependent phosphorylation of p53
    Adler, V
    Pincus, MR
    Minamoto, T
    Fuchs, SY
    Bluth, MJ
    BrandtRauf, PW
    Friedman, FK
    Robinson, RC
    Chen, JM
    Wang, XW
    Harris, CC
    Ronai, Z
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) : 1686 - 1691
  • [2] Post-translational modifications and activation of p53 by genotoxic stresses
    Appella, E
    Anderson, CW
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10): : 2764 - 2772
  • [3] ISOLATION OF HUMAN-P53-SPECIFIC MONOCLONAL-ANTIBODIES AND THEIR USE IN THE STUDIES OF HUMAN P53 EXPRESSION
    BANKS, L
    MATLASHEWSKI, G
    CRAWFORD, L
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1986, 159 (03): : 529 - 534
  • [4] MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY
    BARAK, Y
    JUVEN, T
    HAFFNER, R
    OREN, M
    [J]. EMBO JOURNAL, 1993, 12 (02) : 461 - 468
  • [5] Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity
    Beitel, LK
    Elhaji, YA
    Lumbroso, R
    Wing, SS
    Panet-Raymond, V
    Gottlieb, B
    Pinsky, L
    Trifiro, MA
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 29 (01) : 41 - 60
  • [6] RING domains: Master builders of molecular scaffolds?
    Borden, KLB
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2000, 295 (05) : 1103 - 1112
  • [7] MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS
    CHEN, JD
    MARECHAL, V
    LEVINE, AJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) : 4107 - 4114
  • [8] DEFINITION OF A CONSENSUS BINDING-SITE FOR P53
    ELDEIRY, WS
    KERN, SE
    PIETENPOL, JA
    KINZLER, KW
    VOGELSTEIN, B
    [J]. NATURE GENETICS, 1992, 1 (01) : 45 - 49
  • [9] Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
    Fang, SY
    Jensen, JP
    Ludwig, RL
    Vousden, KH
    Weissman, AM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 8945 - 8951
  • [10] JNK targets p53 ubiquitination and degradation in nonstressed cells
    Fuchs, SY
    Adler, V
    Buschmann, T
    Yin, ZM
    Wu, XW
    Jones, SN
    Ronai, Z
    [J]. GENES & DEVELOPMENT, 1998, 12 (17) : 2658 - 2663